™
The Binding Constraint · The Competitive Map · The Assumption Register · Client Alignment Questions · Every figure sourced.
Download sample outputs to know the depth.
Pages from a real AXLRx Consulting Intelligence Brief.
★ First brief complimentary — a $2,000 engagement, at no cost. No commitment.
Traditional consulting forces a choice — fast or thorough, affordable or rigorous. AXLRx delivers across all four on every engagement.
A brief in your hands in days. No retainer, no kickoff calls, no status updates — just the output before your next decision.
Built to your specific indication, market, and question — not a templatized static report you adapt. Every figure sourced from 50+ live databases and confidence-rated.
Structured the way consulting is done — binding constraints, assumption registers, scenario models, and live working documents you can field and present.
Roughly 90% lower cost than a comparable consulting engagement. Consulting-grade depth at a fraction of the price.
AXLRx delivers the 3–4 weeks of primer work — epidemiology, competitive landscape, access architecture — in days, before the strategy engagement begins.
| AXLRxThe primer, in days | Groundwork In-HouseInternal team or a firm's primer | Syndicated ReportOff-the-shelf | Generic AI ToolChatGPT / Copilot | |
|---|---|---|---|---|
| Time to primer | Days | 3–4 weeks of effort | Off-the-shelf, but fixed | Instant, but unreliable |
| Cost | ~90% lower | Weeks of senior analyst time | $10K–$50K per report | Free / low cost |
| Built to your question | Always, to your brief | Yes — built from scratch | Generic, pre-written | Generic — no pharma context |
| Hard-to-source markets | Any market, globally | Possible — slow to source | Major markets only | Hallucinated — cannot cite |
| Working formats | PDF · PPT · Excel · Word | Yes — hand-built | PDF only | Chat text only |
| Role | The primer before strategy | The same primer, done manually | Market research, pre-written | General queries — no depth |
AXLRx doesn't replace your strategy team or your consulting firm. It does the 3–4 weeks of groundwork that comes before the strategy — so the real work starts with a head start.
A senior MoatRx consultant walks your team through the findings, pressure-tests the assumptions, and helps turn the intelligence into a decision.
Define your engagement across three dimensions. AXLRx applies the frameworks a senior consultant would and builds the brief to exactly that scope.
"What's the addressable patient population for our rare disease asset across the US and EU5, and how does access vary by market?"
"We're closing a BD deal in three weeks. What does the competitive landscape look like for this oncology asset in Japan: approved agents, pipeline, and payer access?"
"We're interviewing 15 KOLs across Brazil and India before our advisory board. Build a ready-to-field discussion guide structured by indication and market."
Each section answers a specific commercial question. Below is what those pages look like in an actual AXLRx brief — the section name, what it contains, and the real page alongside it.
Stated as a claim, documented, and challenged. The page your team argues about, and the one that drives every assumption that follows. Every brief opens here.
PDF · p.05 · Strategic Context
On-market agents, share landscape, and the commercial position behind each brand — structured so you can take a position, not just read a list.
PDF · p.09–15 · Competitive Map
Each parameter carries its basis and confidence level. Change one assumption and the linked model updates. Built to survive an internal challenge meeting.
PDF · p.06 · Assumption Register
Structured by function, ready for your advisory board or internal session. Not a conclusion — a set of decisions your team still needs to make explicit.
PDF · p.16 · Strategic Questions
Sample shown: Alzheimer's Disease, US. Every AXLRx brief is built to your specific indication, market, and commercial question.
Before commissioning one, check whether the answer already exists. 311 reports across 20 indications, searchable on axlrx.ai.
Drawing on 50+ live, cited data sources
The team behind AXLRx, in the press
Consulting-grade intelligence on your timeline, not a retainer schedule.
Market entry, brand planning, and launch readiness, at the pace your commercial decisions require.
02Competitive intelligence, patient sizing, and payer access, built before the deal closes. Deal speed, not engagement speed.
03Accelerate the research and synthesis phase of any pharma commercial engagement, freeing your team for strategy and client delivery.
Pick a real engagement your team is working on now. First brief complimentary, a $2,000 value. Any TA, any market, any question.